SUPN
$41.23+3.49%
Supernus Pharmaceuticals Inc.Stock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.004% of VTIRussell 3000 · 0.003% of IWV
Supernus Pharmaceuticals Inc. monthly returns
Supernus Pharmaceuticals Inc. has averaged 1.77% per month, positive in 54% of months. Month-by-month returns for Supernus Pharmaceuticals Inc. (SUPN) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.8%
166 months
Best month
+34.5%
Mar 2015
Worst month
-29.9%
Dec 2018
Positive months
54%
of all months
Supernus Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -4.2% | |
| Sep 2026 | -2.6% | |
| Aug 2026 | -0.9% | |
| Jul 2026 | -4.0% | |
| Jun 2026 | +0.7% | |
| May 2026 | -3.8% | |
| Apr 2026 | -7.1% | |
| Mar 2026 | -5.6% | |
| Feb 2026 | +13.6% | |
| Jan 2026 | -3.1% | |
| Dec 2025 | +9.0% | |
| Nov 2025 | -17.3% | |
| Oct 2025 | +15.4% | |
| Sep 2025 | +5.9% | |
| Aug 2025 | +28.5% | |
| Jul 2025 | +11.4% | |
| Jun 2025 | -0.6% | |
| May 2025 | -2.4% | |
| Apr 2025 | -0.8% | |
| Mar 2025 | +2.2% | |
| Feb 2025 | -16.4% | |
| Jan 2025 | +6.1% | |
| Dec 2024 | -1.1% | |
| Nov 2024 | +7.3% | |
| Oct 2024 | +9.3% | |
| Sep 2024 | -11.3% | |
| Aug 2024 | +17.9% | |
| Jul 2024 | +11.5% | |
| Jun 2024 | -1.4% | |
| May 2024 | -9.9% | |
| Apr 2024 | -11.8% | |
| Mar 2024 | +14.8% | |
| Feb 2024 | +7.3% | |
| Jan 2024 | -4.4% | |
| Dec 2023 | +6.2% | |
| Nov 2023 | +14.3% | |
| Oct 2023 | -13.5% | |
| Sep 2023 | -13.4% | |
| Aug 2023 | +3.7% | |
| Jul 2023 | +2.1% | |
| Jun 2023 | -9.3% | |
| May 2023 | -10.1% | |
| Apr 2023 | +1.7% | |
| Mar 2023 | -3.6% | |
| Feb 2023 | -8.3% | |
| Jan 2023 | +15.0% | |
| Dec 2022 | -2.9% | |
| Nov 2022 | +7.1% | |
| Oct 2022 | +1.2% | |
| Sep 2022 | -1.1% | |
| Aug 2022 | +7.8% | |
| Jul 2022 | +9.8% | |
| Jun 2022 | +3.8% | |
| May 2022 | -0.1% | |
| Apr 2022 | -13.7% | |
| Mar 2022 | +1.2% | |
| Feb 2022 | +3.6% | |
| Jan 2022 | +5.8% | |
| Dec 2021 | -2.7% | |
| Nov 2021 | +0.4% | |
| Oct 2021 | +11.9% | |
| Sep 2021 | -3.1% | |
| Aug 2021 | +4.6% | |
| Jul 2021 | -14.5% | |
| Jun 2021 | +3.1% | |
| May 2021 | -2.0% | |
| Apr 2021 | +16.3% | |
| Mar 2021 | -2.6% | |
| Feb 2021 | -8.6% | |
| Jan 2021 | +16.8% | |
| Dec 2020 | +18.1% | |
| Nov 2020 | +16.0% | |
| Oct 2020 | -11.9% | |
| Sep 2020 | -5.2% | |
| Aug 2020 | -1.3% | |
| Jul 2020 | -6.2% | |
| Jun 2020 | -1.5% | |
| May 2020 | +3.1% | |
| Apr 2020 | +30.1% | |
| Mar 2020 | +0.0% | |
| Feb 2020 | -21.3% | |
| Jan 2020 | -3.6% | |
| Dec 2019 | +1.5% | |
| Nov 2019 | -15.9% | |
| Oct 2019 | +1.1% | |
| Sep 2019 | +1.7% | |
| Aug 2019 | -19.0% | |
| Jul 2019 | +0.8% | |
| Jun 2019 | +10.2% | |
| May 2019 | -18.2% | |
| Apr 2019 | +4.8% | |
| Mar 2019 | -14.2% | |
| Feb 2019 | +7.1% | |
| Jan 2019 | +14.8% | |
| Dec 2018 | -29.9% | |
| Nov 2018 | -0.3% | |
| Oct 2018 | -5.5% | |
| Sep 2018 | +13.7% | |
| Aug 2018 | -16.3% | |
| Jul 2018 | -11.5% | |
| Jun 2018 | +6.2% | |
| May 2018 | +20.1% | |
| Apr 2018 | +2.4% | |
| Mar 2018 | +17.7% | |
| Feb 2018 | -0.4% | |
| Jan 2018 | -2.0% | |
| Dec 2017 | +5.4% | |
| Nov 2017 | -9.1% | |
| Oct 2017 | +4.0% | |
| Sep 2017 | -12.7% | |
| Aug 2017 | +13.2% | |
| Jul 2017 | -6.1% | |
| Jun 2017 | +14.6% | |
| May 2017 | +15.3% | |
| Apr 2017 | +4.2% | |
| Mar 2017 | +21.8% | |
| Feb 2017 | -5.0% | |
| Jan 2017 | +7.1% | |
| Dec 2016 | +17.2% | |
| Nov 2016 | +8.8% |
Monthly total return (since Nov 2021)#
-20%-10%0%10%20%
Nov 2021+0.4%
Dec 2021-2.7%
Jan 2022+5.8%2022
Feb 2022+3.6%
Mar 2022+1.2%
Apr 2022-14%
May 2022-0.11%
Jun 2022+3.8%
Jul 2022+9.8%
Aug 2022+7.8%
Sep 2022-1.1%
Oct 2022+1.2%
Nov 2022+7.1%
Dec 2022-2.9%
Jan 2023+15%2023
Feb 2023-8.3%
Mar 2023-3.6%
Apr 2023+1.7%
May 2023-10%
Jun 2023-9.3%
Jul 2023+2.1%
Aug 2023+3.7%
Sep 2023-13%
Oct 2023-13%
Nov 2023+14%
Dec 2023+6.2%
Jan 2024-4.4%2024
Feb 2024+7.3%
Mar 2024+15%
Apr 2024-12%
May 2024-9.9%
Jun 2024-1.4%
Jul 2024+11%
Aug 2024+18%
Sep 2024-11%
Oct 2024+9.3%
Nov 2024+7.3%
Dec 2024-1.1%
Jan 2025+6.1%2025
Feb 2025-16%
Mar 2025+2.2%
Apr 2025-0.82%
May 2025-2.4%
Jun 2025-0.57%
Jul 2025+11%
Aug 2025+29%
Sep 2025+5.9%
Oct 2025+15%
Nov 2025-17%
Dec 2025+9.0%
Jan 2026-3.1%2026
Feb 2026+14%
Mar 2026-5.6%
Apr 2026-7.1%
May 2026-3.8%
Jun 2026+0.71%
Jul 2026-4.0%
Aug 2026-0.94%
Sep 2026-2.6%
Oct 2026-4.2%
Supernus Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2013, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -4.21% — 9th of 14 Octobers since 2013 at the last close; the average October returned -0.1%.
| Month | −35%0+35% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +5.4% | +6.0% | 64% | +29.6% 2014 | -15.6% 2016 | |
| Feb | -0.7% | +1.3% | 50% | +13.6% 2026 | -21.3% 2020 | |
| Mar | +3.6% | +0.6% | 50% | +34.5% 2015 | -26.6% 2013 | |
| Apr | +2.0% | +2.1% | 57% | +30.1% 2020 | -13.7% 2022 | |
| May | +4.3% | +1.5% | 50% | +34.4% 2013 | -18.2% 2019 | |
| Jun | +4.7% | +3.5% | 64% | +22.9% 2014 | -9.3% 2023 | |
| Jul | +0.9% | +1.5% | 57% | +24.9% 2015 | -20.9% 2014 | |
| Aug | +1.5% | +1.4% | 50% | +28.5% 2025 | -19.0% 2019 | |
| Sep | -2.0% | -2.9% | 36% | +15.7% 2016 | -22.7% 2015 | |
| Oct | -0.1% | +1.1% | 54% | +17.6% 2015 | -19.9% 2016 | |
| Nov | +1.7% | +2.3% | 62% | +16.0% 2020 | -17.3% 2025 | |
| Dec | +0.1% | +1.5% | 54% | +18.1% 2020 | -29.9% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from SUPN's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Supernus Pharmaceuticals Inc.'s average monthly return?
- Supernus Pharmaceuticals Inc. (SUPN) has averaged about 1.77% per month, positive in roughly 54% of months. The best month was Mar 2015 (+34.5%) and the worst was Dec 2018 (-29.9%).
More on Supernus Pharmaceuticals Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100